Wrestling fans who were unfamiliar LJ Cleary were introduced to the Irish professional wrestler at WWE Backlash earlier this ...

Lyra's LYR-210 met key goals in a Phase 3 trial for chronic rhinosinusitis, showing early and sustained symptom relief with a ...

Lyra also reported success on key secondary endpoints. These included improvements in broader symptom scores and patient ...

Becky Lynch and Lyra Valkyria clash once again for the women's Intercontinental title at WWE Money in the Bank — this is the ...

Will the third time be the charm for Becky Lynch? Women's Intercontinental Champion Lyra Valkyria revealed in WWE Digital ...

Shares of Lyra Therapeutics Inc. soared more than 310% on data from its second phase III trial testing drug-device candidate ...

Lyra Valkyria reflects on learning that she would be crowned the first-ever Women's Intercontinental Champion.

Here are the five things you need to know, including Lyra's good news, Sanofi's acquisition, Mass. biotech jobs, inside Market Basket's board, AI, and hiring entry-level jobs.

Lyra Growth Partners Inc. ("Lyra") announces that, on May 28, 2025, Lyra completed the private sale of an aggregate of ...

Lyra Valkyria stepped into the ring with Becky Lynch at WWE Backlash, successfully defending her WWE Intercontinental ...

ENLIGHTEN 2 trial met primary endpoint with LYR-210 demonstrating statistically significant improvement in the composite of the three cardinal symptoms (3CS) of CRS at 24 weeks (p=0.0078 ...

WWE Network, including WWE Money in the Bank and all Premium Live Events, is available in the United States exclusively on ...